4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Celldex Therapeutics, Inc. (CLDX) operates in the Biotechnology industry and is headquartered in Hampton, United States with about 198 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, CLDX reported $2M in revenue and ($259M) in net income.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
Interactive charts & full statements → Open the CLDX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $7M | $7M | $2M | — |
| Operating Income (EBIT) | ($287M) | ($195M) | ($142M) | ($107M) | — |
| Net Income | ($259M) | ($158M) | ($141M) | ($112M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $1M |
| Operating Income (EBIT) | ($84M) | ($87M) | ($74M) | ($64M) | ($63M) |
| Net Income | ($79M) | ($81M) | ($67M) | ($57M) | ($54M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $583M | $792M | $466M | $353M | — |
| Total Liabilities | $56M | $45M | $36M | $26M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLDX viewer.
About TickerBase · Data methodology & sources